Thanks, Michael. For the past year, it has been our view that inflation would remain elevated and the higher interest rate environment will last longer than some market observers expected. Our view has largely proven accurate and should our views continue to play out, we believe floating rate asset structures, coupled with investment strategies focused on large defensive portfolio companies and asset-based finance investments directly side to financial and hard assets will remain attractive. Looking ahead, it is our expectation that the economy will experience stickier inflation in the near term, coupled with continued, albeit slowing overall economic growth. As Michael highlighted earlier, there are strong tailwinds to our business as sponsors continue to utilize private credit solutions to finance transactions. Origination activity picked up meaningfully in the first quarter compared to the prior few quarters, and we expect a material increase in private market transaction activity during 2024. Given significant private equity dry powder, combined with pent-up demand from an M&A perspective and the desire for private equity fund LPs to see a higher level of return of capital. As we mentioned on our last call, the macro backdrop created challenges for a few of our portfolio companies during the fourth quarter of last year. Our workout team has been active on these names. And as Brian will discuss, we're pleased to have achieved positive results quickly. And while there's still work to be done, reducing our non-income and nonaccrual investments, we clearly are pleased with the recent progress we've made. Turning to investment activity. During the first quarter, we originated $1.4 billion of new investments. Approximately 75% of our new investments were focused on add-on financings to existing portfolio companies and long-term KKR relationships. Our new investments combined with $1.7 billion of net sales and repayments, when factoring in sales to our joint venture, equated to a net portfolio decrease of $221 million. New originations consisted of approximately 69% in first lien loans, 3% in second lien loans, 3% in other senior secured debt, 1% in subordinated debt and 24% in asset-based finance investments. As we mentioned on our last call, with regard to new investments, we're continuing to see tighter pricing in the upper end of the middle market. The trade-off to the spread compression is still strong documentation and very solid credit profiles. We also continue to be pleased with the quality of the new deals. During the first quarter, our new direct lending investments had a weighted average EBITDA of approximately $243 million, 5.7x leverage through our security and a 47% equity contribution, all with a weighted average coupon of approximately SOFR plus 570 basis points. One example of a new deal in the quarter was our investment in Curia Global, a manufacturer of active pharmaceutical ingredients, who provides contract pharmaceutical development, manufacturing, packaging and analytical services. KKR was the sole lender as we provided $125 million off-balance sheet SPV structured trade receivables facility secured by Curia U.S. receivables. Pricing was 625 basis points with a 2% upfront fee. FSK committed $83 million of the $125 million facility. Additionally, in the first quarter, KKR and its affiliates, along with other partners purchased GreenSky, a point-of-sale finance company from Goldman Sachs as part of its divestiture from consumer-related businesses. GreenSky was founded in 2006 and focuses on offering home improvement financing alternatives for prime borrowers. FSK committed $80 million to the transaction. I also want to highlight a sale of the music IP investment in KKR Chord IP Aggregator that occurred during the first quarter. In connection with this sale, FSK received an $89 million return of capital. FSK Chord IP Aggregator also received a well-collateralized seller note that is expected to be repaid during 2024. And FSK's respective share of the seller note is approximately $30 million. The transaction resulted in a $20 million gain to our net asset value, and we expect to realize an IRR of approximately 18% on our position. When we look at the aggregate trends across our portfolio companies, we've continued to see high single-digit EBITDA growth with modest margin pressure due to the continued inflationary environment. Over the coming quarters, while we expect continued revenue growth from our portfolio companies, we'd expect growth to slow modestly as macro trends could potentially lead to a slowdown in economic growth. The weighted average EBITDA of our portfolio companies was $218 million as of March 31, 2024. Additionally, our portfolio companies reported a weighted average year-over-year EBITDA growth rate of approximately 7% across companies in which we've invested in since April of 2018. And with that, I'll turn the call over to Brian to discuss our portfolio in more detail.